TAPI, a peptide-focused CDMO, has described deploying UV and RI monitoring alongside in-line mass spectrometry-based sequence verification to create a data-rich manufacturing environment that replaces retrospective batch testing with continuous in-process quality assurance
Now their stomachs are paralyzed July 25, 2023 Facial lipoatrophy with semaglutide-related weight loss February 10, 2023 --------------------------------------- Glucagon-like peptide 1 (GLP-1) agonists are medications approved for treatment of diabetes that recently have also been used off label for weight loss.1 Studies have found increased risks of gastrointestinal adverse events (biliary disease,2 pancreatitis,3 bowel obstruction,4 and gastroparesis5) in patients with diabetes.2-5 Because such patients have higher baseline risk for gastrointestinal adverse events, risk in patients taking these drugs for other indications may differ
Public Health 20 (4), 2868
Expert Opinion on Drug Delivery 14 , 983995, (2017)
As the precursor to SAMe (S-adenosylmethionine) the body's universal methyl donor methionine is essential for the normal methylation reactions that support hepatic phosphatidylcholine synthesis and lipid export
